Nagoya University · Medicine
Professor Takahiro Okumura's research lab focuses on advancing heart failure management, particularly in the context of aging populations and early-stage disease progression. The lab specializes in developing predictive tools—such as the LVRR predicting score—for identifying patients at risk of left ventricular reverse remodeling in dilated cardiomyopathy, aiming to improve clinical decision-making. A key research direction involves integrating palliative care principles into the early management of heart failure to reduce suffering and optimize outcomes, even in patients receiving active treatment. The lab also investigates risk stratification and end-of-life care strategies tailored to elderly populations in aging societies.
Figures are computed from collected data and may differ slightly.
The LVRR predicting score using five predictors including hypertension, no family history of DCM, symptom duration <90 days, LVEF <35%, and QRS duration <116 ms can stratify the LVRR rate in patients with DCM. The LVRR predicting score may be a useful clinical tool that can be used easily at any institution.
The populations of Asian countries are expected to age rapidly in the near future, with a dramatic increase in the number of heart failure (HF) patients also anticipated. The need for palliative and end-of-life care for elderly patients with advanced HF is currently recognized in aging societies. However, palliative care and active treatment for HF are not mutually exclusive, and palliative care should be provided to reduce suffering occurring at any stage of symptomatic HF after the point of di
Open papers in the app to read, cite, and organize with AI.
